The exact mechanisms through which activation of THR improves MASH are still unclear but are known to control fat synthesis, regulate fatty acid oxidation, regulate cholesterol metabolism, improve mitochondrial function, and reduce inflammation and fibrosis
When GLP-1R is activated, microglial activation is suppressed, reducing the levels of VEGF and other cytokines involved in neovascularization
GLP-1 receptor agonists such as semaglutide can help manage blood glucose, body weight, and certain cardiometabolic risks when prescribed for an appropriate patient
Most women normalize within three to six months
The New England Journal of Medicine, 389 (10), 877888
Campins L, Camps M, Riera A, Pleguezuelos E, Yebenes JC, Serra-Prat M